Walgreens Boots Alliance (WBA) Projected to Post Quarterly Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) is expected to be releasing its Q3 2025 earnings data before the market opens on Thursday, June 26th. Analysts expect the company to announce earnings of $0.34 per share and revenue of $36.72 billion for the quarter.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 3.80% and a positive return on equity of 16.39%. The firm had revenue of $38.59 billion during the quarter, compared to analysts' expectations of $37.90 billion. During the same period in the prior year, the company posted $1.20 EPS. The company's revenue was up 4.1% on a year-over-year basis. On average, analysts expect Walgreens Boots Alliance to post $2 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $11.39 on Thursday. Walgreens Boots Alliance has a 52-week low of $8.08 and a 52-week high of $16.25. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.32 and a current ratio of 0.61. The firm has a 50 day moving average price of $11.13 and a two-hundred day moving average price of $10.71. The stock has a market cap of $9.86 billion, a P/E ratio of -1.70, a price-to-earnings-growth ratio of 1.37 and a beta of 0.78.

Insider Transactions at Walgreens Boots Alliance

In other news, Chairman Stefano Pessina acquired 832,258 shares of the business's stock in a transaction dated Sunday, April 27th. The stock was bought at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the transaction, the chairman now owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. The trade was a 0.57% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 17.50% of the company's stock.

Institutional Investors Weigh In On Walgreens Boots Alliance

An institutional investor recently bought a new position in Walgreens Boots Alliance stock. United Services Automobile Association acquired a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 18,947 shares of the pharmacy operator's stock, valued at approximately $212,000. Hedge funds and other institutional investors own 58.59% of the company's stock.

Analysts Set New Price Targets

WBA has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price objective for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Finally, Wall Street Zen started coverage on shares of Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating for the company. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.